Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-27

Clinical Trial Update: Bedaquiline Roll-out Evidence in Contacts and People Living With HIV to Prevent TB [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial update evaluating bedaquiline to prevent tuberculosis among contacts of TB patients and people living with HIV, focusing on latent TB…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • bedaquiline (bedaquiline)

Snippet

Sponsor: Johns Hopkins University | Conditions: Tuberculosis, Latent | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING